| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |